Vildarise M Tablet

Composition of Vildarise M Tablet

Vildarise M Tablet contains Vildagliptin 50 mg + Metformin 500 mg (likely, strength to be confirmed). It belongs to the DPP-4 inhibitor + Biguanide class of medicines.

Uses of Vildarise M Tablet

Treatment of type 2 diabetes mellitus to improve blood sugar control along with diet and exercise; used when single medicine is insufficient.

Key benefits

• Lowers fasting and post-meal blood glucose
• Improves insulin response in a glucose-dependent manner
• Helps reduce hepatic glucose production
• May aid weight neutrality compared with some antidiabetics
• Convenient combination therapy for type 2 diabetes

How Vildarise M Tablet works

Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1/GIP), enhancing glucose-dependent insulin release and reducing glucagon. Metformin decreases hepatic glucose production and improves insulin sensitivity, lowering blood glucose without usually causing hypoglycaemia when used alone.

How to take Vildarise M Tablet

Oral tablet; take exactly as prescribed, usually with meals to reduce stomach upset (especially due to metformin). Swallow whole with water; do not crush/chew. Follow diet/exercise advice and monitor blood glucose regularly.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take the missed dose of Vildarise M as soon as you remember. If it is almost time for the next dose, skip the missed one and carry on with the usual schedule. Do not take two doses together to make up for a missed dose.

If you take too much

Taking more Vildarise M than prescribed can be harmful. If you suspect an overdose, contact a doctor or go to the nearest emergency department at once, and carry the pack or strip with you. In India the emergency number is 112.

Side effects of Vildarise M Tablet

Most side effects of Vildarise M are mild and settle as the body adjusts. Reported side effects include:

• Nausea
• vomiting
• diarrhoea
• abdominal pain
• loss of appetite
• metallic taste
• headache
• dizziness
• upper respiratory tract infection
• hypoglycaemia (more likely with other antidiabetics)
• low vitamin B12 (long-term)

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Vildarise M Tablet

Warnings and precautions

Prescription medicine. Risk of lactic acidosis with metformin (higher in kidney disease, dehydration, severe infection, heavy alcohol use, liver disease, or low oxygen states); stop and seek care if rapid breathing, severe weakness, abdominal pain, or unusual sleepiness occurs. Check kidney function before and during therapy; not recommended in severe renal impairment. Temporarily stop metformin before/after iodinated contrast procedures or major surgery as advised. Monitor for pancreatitis symptoms (severe abdominal pain), allergic reactions, and liver enzyme elevation; periodic LFTs may be advised. Use caution in elderly and in conditions causing dehydration.

Interactions with other medicines

Alcohol (increases lactic acidosis risk), iodinated contrast media, carbonic anhydrase inhibitors (e.g., topiramate/acetazolamide), cimetidine, diuretics, ACE inhibitors, corticosteroids, thyroid hormones, sympathomimetics, other antidiabetics (insulin/sulfonylureas increase hypoglycaemia risk)

How to store Vildarise M Tablet

Store below 25°C in a dry place; protect from moisture and light; keep in original pack and out of reach of children.

Manufacturer and class

Manufacturer:

SUNRISE PHARMACEUTICALS

Therapeutic class:

Antidiabetic

Drug class:

DPP-4 inhibitor + Biguanide